Clinical Trials Browser

Active not recruiting × Interventional × Breast Diseases × Clear all

Breast Diseases, Breast Neoplasms, Uterine Cervical Neoplasms, Genital Neoplasms, Female, Neoplasms, Neoplasms by Site, Ovarian Neoplasms, Prostatic Neoplasms, Urogenital Neoplasms, Uterine Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT05720039 2026-02-24

SP NSM

Phase NA Active not recruiting

204 enrolled

Breast

Breast Diseases, Breast Neoplasms

NCT04711252 2025-10-14

SERENA-4

Phase 3 Active not recruiting

1,370 enrolled

Breast

Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, Neoplasms, Neoplasms by Site, Skin Diseases

NCT03304080 2025-07-18

Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic Breast

Phase 1/2 Active not recruiting

44 enrolled

Breast

Breast Diseases, Breast Neoplasms

NCT03709446 2025-07-08

Leflunomide in Previously Treated Metastatic Triple Negative Cancers

Phase 1/2 Active not recruiting

17 enrolled

Breast

Breast Diseases, Breast Neoplasms, Triple Negative Breast Neoplasms

NCT04711109 2025-04-02

BRCA-P

Phase 3 Active not recruiting

300 enrolled

Breast

Breast Diseases, Breast Neoplasms, Neoplasms

NCT05441943 2024-03-05

Lymphaticovenous Anastomosis as Treatment for Lymphedema

Phase NA Active not recruiting

10 enrolled

Breast

Breast Cancer Lymphedema, Breast Diseases, Breast Neoplasms, Lymphatic Diseases, Lymphedema, Neoplasms, Pathologic Processes, Postoperative Complications, Skin Diseases

Clinical Trials

A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

SP NSM

SERENA-4

Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic Breast

Leflunomide in Previously Treated Metastatic Triple Negative Cancers

BRCA-P

Lymphaticovenous Anastomosis as Treatment for Lymphedema